SOM230 LAR (pasireotide long-acting release)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SOM230 LAR (pasireotide long-acting release), covering 2016-02-12 to 2016-02-12. Get the full timeline:
Most recent: Clinical Trial Update: SOM230 LAR With Bortezomib and Dexamethasone for Refractory or Relapsed Multiple Myeloma [Phase 2]